| Literature DB >> 34401555 |
Mario Dioguardi1, Mario Alovisi2, Diego Sovereto1, Giuseppe Troiano1, Giancarlo Malagnino1, Michele Di Cosola1, Angela Pia Cazzolla1, Luigi Laino3, Lorenzo Lo Muzio1.
Abstract
OBJECTIVES: The purpose of this systematic review of the literature is to investigate which of the epoxy-based cements and those based on Tricalciumsilicate (MTA, Bioceramic) have the best sealing capacity through the analysis of studies that have provided a survey model in vitro of bacteria leakage. SOURCE: The articles were identified using electronic databases such as PubMed, Scopus, the search was conducted between 8.12.2020 and 31.12.2020 and a last search was conducted on 2.12.2021. STUDY SELECTION: 678 records were identified and after removing the duplicates we obtain 481 records, with the first phase of screening and selection of records we reached 204 and with the application of the inclusion and exclusion criteria we selected 31 articles, only 9 studies made a direct comparison between the two endodontic cement categories and presented data that could be included in the metaanalysis. DATA: The meta-analysis of first outcome shows an odds ratio of 2.70 C.I.(Confidence Interval) [1.54, 4.73], the test for overall effect has a p value = 0.0005 with a heterogeneity index of I 2 of 9%; The second outcome meta-analysis shows an Odds Ratio of 1.50 C.I. (Confidence Interval) [0.92, 2.46] with a p value of 0.10 with an I 2 of 79%.Entities:
Keywords: Endodontic; Epoxy resin; MTA; Microbial leakage; Sealing ability
Year: 2021 PMID: 34401555 PMCID: PMC8353296 DOI: 10.1016/j.heliyon.2021.e07494
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Inclusion and exclusion criteria.
| Category | Exclusion Criteria | Inclusion Criteria |
|---|---|---|
| Publication Language | Not English | English |
| Study types | Review, Systematic review, case report, case series, Clinical Study, study in vitro not ex vivo. | Study in vitro ex vivo |
| data characteristics | Report data over a period of less than 60 days. | Report data on the number of infiltrated samples in a period of over 60 days, report data on both types of cement (Tricalciumsilicate and epoxy resins). |
| Risk of Bias | High risk of bias. | Medium o low risk of bias. |
Performed on extracted teeth.
Overview of the search methodology; Records identified by databases:678, 485 after removing overlaps. Articles included in meta-analysis: 9.
| Database - Provider | Key words | Search Details | Number of records | articles After removing overlaps articles | remaining articles that dealt with the issue of sealing ability for endodontic cements under review | Article remaining after applying the inclusion and exclusion criteria | Articles included in meta-analysis |
|---|---|---|---|---|---|---|---|
| Pub med | "epoxy resin sealer" | "epoxy resin sealer"[All Fields] | 53 | ||||
| Pub med | calcium silicate sealer | ("calcium silicate"[Supplementary Concept] OR "calcium silicate"[All Fields]) AND ("sealer"[All Fields] OR "sealers"[All Fields]) Translations calcium silicate: "calcium silicate"[Supplementary Concept] OR "calcium silicate"[All Fields] sealer: "sealer"[All Fields] OR "sealers"[All Fields] | 181 | ||||
| Scopus | epoxy resin sealer" | TITLE-ABS-KEY (“epoxy resin sealer”) | 77 | ||||
| Scopus | calcium silicate sealer | TITLE-ABS-KEY (“calcium silicate sealer”) | 17 | ||||
| Pub med | bioceramic AND endodontic | ("bioceramic"[All Fields] OR "bioceramics"[All Fields]) AND ("endodontal"[All Fields] OR "endodontic"[All Fields] OR "endodontical"[All Fields] OR "endodontically"[All Fields] OR "endodontics"[MeSH Terms] OR "endodontics"[All Fields]) | 226 | ||||
| Scopus | bioceramic AND endodontic | TITLE-ABS-KEY (bioceramic AND endodontic) | 124 | ||||
| Web of science | epoxy resin sealer | You searched for: TOPIC: (epoxy resin sealer) | 337 | ||||
| Web of science | You searched for: TOPIC: (bioceramic AND endodontic) | 115 | |||||
| 1130 | 481 | 204 | 31 | 9 |
Figure 1PRISMA 2009 flow diagram.
Number of total and leaked samples, based on the time elapsed (10–120 days). MTA-PG: Mineral trioxide aggregate, Propylene glycole; AH26 (Dentsply, DeTrey, Konstanz, Germany) and MTA Fillapex (Angelus, Londrina, Brazil), Apatite Root Canal Sealer (Sankin-Kogyo, Tokyo, Japan), CPM: Portland cement (EGEO SLR, MTM Argentina SA, Buenos Aires, Argentina), MTA (Angelus, Londrina, Paraná, Brazil), MBPc (University of São Paulo, Brazil, epoxy resin sealer containing calcium hydroxide), AH Plus (Dentsply DeTrey, Konstanz, Germany), Resilon (Real Seal®, Sybron Endo, Glendora, USA), Super-EBA (Harry J. Bosworth, Skokie, IL, USA), ProRoot MTA (Dentsply Sirona), AHP: AH Plus, ESE: Epiphany SE (Pentron Clinical Technologies, LLC., Wallingford, CT, USA); SEL: Sealapex (Kerr Corp., CA, USA); AGP: Activ GP (Brasseler USA, Dental Instrumentation, USA); EDF: Endofill, (Dentsply Industria e Comercio Ltda, Petropolis, RJ, Brazil); CPM: Endo CPM Sealer (EGEO S.R.L. under license of MTM Argentina S.A., Buenos Aires, Argentina); MTAS: MTA Sealer (Araraquara Dental School, UNESP, Brazil); BCS: bioceramic sealer (Totalfill BC Sealer, FKG Dentaire SA, La Chaux-de-Fonds, Switzerland); GP: gutta percha; BCC: bioceramic-impregnated gutta percha cone; BioRoot RCS: BioRoot root canal sealer (Septodont, Saint Maur-des-Fosses, France).
| First author, data, reference | endodontic cements tested | number of samples | number of samples with leakage | Bacteria | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90 | 120 days | |||||
| Milani, 2019 [ | MTA-PG in dry canals | 15 | 45 | 7 | ||||||||||
| MTA-PG in wet canals | 15 | 12 | ||||||||||||
| MTA fillapex | 15 | 14 | ||||||||||||
| AH26 | 15 | 15 | 10 | |||||||||||
| Jafari 2016 [ | AH26 | 44 | 44 | 7 | ||||||||||
| MTA fillapex | 44 | 44 | 10 | |||||||||||
| Apatite Root Canal Sealer | 44 | 11 | ||||||||||||
| Medeiros 2016 [ | white MTA, | 20 | 7 | 7 | 7 | 7 | ||||||||
| CPM, | 20 | 4 | 4 | 4 | 4 | |||||||||
| MBPc | 20 | 1 | 1 | 2 | 2 | |||||||||
| Amezcua 2015 [ | SuperEBA | 10 | ||||||||||||
| RealSeal® thermoplasticized | 10 | 9 | ||||||||||||
| ProRoot® MTA | 10 | 10 | ||||||||||||
| Thermoplasticized gutta-percha + AH Plus® | 10 | 7 | ||||||||||||
| Oliveira 2011 [ | AHP | 15 | 30 | 5 | 7 | 8 | 9 | |||||||
| S26 | 15 | 8 | 9 | 9 | 10 | |||||||||
| ESE | 15 | 4 | 9 | 11 | 12 | |||||||||
| SEL | 15 | 7 | 7 | 8 | 11 | |||||||||
| AGP | 15 | 6 | 11 | 14 | 14 | |||||||||
| EDF | 14 | 7 | 7 | 11 | 12 | |||||||||
| CPM | 15 | 9 | 10 | 12 | 13 | |||||||||
| MTAS | 13 | 13 | 8 | 10 | 11 | 12 | ||||||||
| Razavian 2016 [ | AH 26 | 25 | 5 | |||||||||||
| MTA Fillapex | 25 | 16 | ||||||||||||
| Reyhani 2015 [ | AH Plus | 15 | 11 | 12 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | |||
| AH Plus post | 15 | 11 | 12 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | ||||
| MTA Fillapex | 15 | 7 | 8 | 8 | 9 | 9 | 11 | 13 | 14 | 15 | ||||
| MTA Fillapex post | 15 | 6 | 8 | 9 | 10 | 10 | 11 | 14 | 15 | 15 | ||||
| Yanpiset 2018 [ | GP/AH plus | 20 | 4 | |||||||||||
| BCC/AH plus | 20 | 9 | ||||||||||||
| GP/BCS | 20 | 9 | ||||||||||||
| BCC/BCS | 20 | 5 | ||||||||||||
| Antunovic 2021 [ | BCS | 14 | 56 | 0 | 2 | |||||||||
| BioRoot RCS | 14 | 1 | 5 | |||||||||||
| MTA Fillapex | 14 | 2 | 5 | |||||||||||
| MTA Plus | 14 | 5 | 7 | |||||||||||
| AH Plus | 14 | 14 | 1 | 11 | ||||||||||
Assessment of the risk of bias within the studies, with scores 7 to 12 = low quality, 13 to 20 = intermediate quality, and 21 to 25 = high quality.
| First Author, Data | Sample size calculation | Meaningful difference between groups | Sample preparation and handling | Allocation sequence, randomization and blinding | Statistical analysis | Score | outcome |
|---|---|---|---|---|---|---|---|
| Milani, 2019 [ | 3 | 3 | 4 | 3 | 4 | 17 | 1 |
| Jafari 2016 [ | 4 | 3 | 3 | 3 | 4 | 17 | 1 |
| Medeiros 2016 [ | 4 | 3 | 4 | 3 | 3 | 17 | 1, 2 |
| Amezcua 2015 [ | 2 | 3 | 4 | 4 | 4 | 17 | 2 |
| Oliveira 2011 [ | 3 | 3 | 3 | 2 | 3 | 14 | 1, 2 |
| Razavian 2016 [ | 4 | 3 | 4 | 4 | 2 | 17 | 1, 2 |
| Reyhani 2015 [ | 3 | 3 | 4 | 3 | 3 | 16 | 1,2 |
| Yanpiset 2018 [ | 4 | 3 | 4 | 3 | 4 | 18 | 2 |
| Antunovic 2021 [ | 3 | 3 | 4 | 3 | 4 | 17 | 2 |
Figure 2Funnel plots of the evaluation of heterogeneity for first outcome.
Figure 3Funnel plot for the secondary outcome. The arrows highlight the sources of heterogeneity (I2 79%) Antunovic 2021, Reyhani 2015.
Figure 4Forest plot of the fixed effects model of the meta-analysis of the first outcome.
Figure 5Forest plot of the fixed effects model of the meta-analysis of secondary outcome.
Figure 6Sensitivity analysis: Forest plot of the meta-analysis of the secondary outcome; the arrows indicate the sources of heterogeneity that are identified by the funnel plot and are also evident on the forest plot.